| tips : |
Žurnāls |
| interneta saite : |
http://archive.hospital-pharmacy.com/doi/ref/10.1310/hpj5007-609 |
|
| pētniecības grupas : |
San Francisco - Theravance Biopharma |
| Autori : |
Gu Z, Wong A, Raquinio E, Nguyen A. |
| Nosaukums : |
Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags. |
| Numurs : |
Hosp Pharm ; 50, 7: 609-614. 2015 |
|
| Pierādījumu līmeni : |
|
| fizikālā stabilitāte : |
|
| ķīmiskā stabilitāte : |
|
| citas metodes : |
|
| komentāri : |
| Degradēšanās produkti identificēti un noteikts to daudzums |
|
Saraksti
 Telavancin hydrochloride
|
 |
 |
 |
 |
0.6 mg/ml |
-20°C |
 |
| 32 |
 |
|
|
|
|
|
8 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
 |
0.6 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
|
8 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
 |
|
0.6 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
|
8 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
|
0.6 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
|
8 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
